The Associated Press reported recently that
the nation's federal health officials are worried about biological
weaponry treatment stockpiles. There is a stockpile of 60 million 60 day
anthrax treatments, small pox vaccines, and adapted small pox vaccines
for the uncompromising but there is a growing concern for the
preparation for a number of other illnesses. As a result of this
pressure, pharmaceutical companies are now drawn to a push for the
development of multipurpose treatments in order to expedite the
preparation process. What will this new multipurpose drug fad yield?...
No comments:
Post a Comment